Align Technology buy Midas
Summary
This prediction ended on 20.12.19 with a price of €246.40. The BUY prediction by Midas finished with a performance of 29.97%. Midas has 50% into this predictionAlign Technology (NASDAQ: ALGN) is a leading global medical device company specializing in the design, manufacture, and marketing of comprehensive orthodontic systems. Their flagship product, the Invisalign system, revolutionizes traditional orthodontic treatment by offering an innovative clear-aligner solution that guides teeth into proper alignment without the use of conventional metal braces or wires. Founded in 1997, Align Technology has expanded its product portfolio to include iTero intraoral scanning and CAD/CAM technologies, alongside spearheading research and development in dental solutions. By embracing digital technology and focusing on patient convenience and comfort, Align has quickly established itself as a significant player within the growing dental and orthodontic industry, consistently leading the charge for new, non-invasive solutions to dental malocclusion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Align Technology | -6.440% | -6.440% | -10.729% | -44.012% |
| iShares Core DAX® | -1.670% | -1.001% | 10.864% | 12.563% |
| iShares Nasdaq 100 | -4.184% | -1.145% | 37.458% | 41.078% |
| iShares Nikkei 225® | -4.967% | -5.783% | 18.828% | 0.655% |
| iShares S&P 500 | -2.834% | -0.572% | 25.875% | 39.960% |
Comments by Midas for this prediction
In the thread Align Technology diskutieren